Levels of syndecan-1 and hyaluronan in early- and late-onset preeclampsia

被引:17
作者
Kornacki, Jakub [1 ]
Wirstlein, Przemyslaw [1 ]
Wender-Ozegowska, Ewa [1 ]
机构
[1] Poznan Univ Med Sci, Dept Obstet Gynecol & Gynecol Oncol, Div Reprod, Poznan, Poland
关键词
Preeclampsia; Endothelial injury; Glycocalyx; Placental insufficiency; ANGIOGENIC FACTORS; DIAGNOSIS; UPDATE;
D O I
10.1016/j.preghy.2019.08.165
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The study aimed to assess serum levels of syndecan-1 (SDC-1) and hyaluronan (HA) in patients with early- and late-onset preeclampsia (PE). Study design: Blood samples were collected in the third trimester of pregnancy from 20 women with early-onset PE, 20 with late-onset PE, and 20 with normal pregnancy for the assessment of serum levels of SDC-1 and HA as markers of endothelial injury. PE was categorized as early-onset when diagnosed at < 34 weeks of gestation and as late-onset when diagnosed at >= 34 weeks of gestation. Main outcome measures: The degree of endothelial injury in different forms of preeclampsia expressed by serum concentrations of SDC-1 and HA. Results: Concentration of HA was significantly higher and the level of SDC-1 was significantly lower in patients with PE than in the control group. However, the concentrations of both HA and SDC-1 did not differ significantly between the two groups of PE. Conclusions: Degree of endothelium injury is comparable in patients with early- and late-onset PE.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 13 条
  • [1] [Anonymous], 2013, OBSTET GYNECOL, V122, P1122, DOI [10.1097/01.AOG0000437382.03963.88, DOI 10.1097/01.AOG0000437382.03963.88]
  • [2] Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases
    Dogne, Sophie
    Flamion, Bruno
    Caron, Nathalie
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (07) : 1427 - 1439
  • [3] Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-Based Management Protocol
    Figueras, Francesc
    Gratacos, Eduard
    [J]. FETAL DIAGNOSIS AND THERAPY, 2014, 36 (02) : 86 - 98
  • [4] Low Soluble Syndecan-1 Precedes Preeclampsia
    Gandley, Robin E.
    Althouse, Andrew
    Jeyabalan, Arundhathi
    Bregand-White, Julia M.
    McGonigal, Stacy
    Myerski, Ashley C.
    Gallaher, Marcia
    Powers, Robert W.
    Hubel, Carl A.
    [J]. PLOS ONE, 2016, 11 (06): : 1 - 18
  • [5] Angiogenic Factors in Preeclampsia From Diagnosis to Therapy
    Karumanchi, S. Ananth
    [J]. HYPERTENSION, 2016, 67 (06) : 1072 - 1079
  • [6] Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications
    Kim Y.-H.
    Nijst P.
    Kiefer K.
    Tang W.H.W.
    [J]. Current Heart Failure Reports, 2017, 14 (2) : 117 - 126
  • [7] Kornacki J, 2008, GINEKOL POL, V79, P432
  • [8] Update on the Pathophysiological Implications and Clinical Role of Angiogenic Factors in Pregnancy
    Llurba, Elisa
    Crispi, Fatima
    Verlohren, Stefan
    [J]. FETAL DIAGNOSIS AND THERAPY, 2015, 37 (02) : 81 - 92
  • [9] Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy
    Oltean, Sebastian
    Qiu, Yan
    Ferguson, Joanne K.
    Stevens, Megan
    Neal, Chris
    Russell, Amy
    Kaura, Amit
    Arkill, Kenton P.
    Harris, Kirstie
    Symonds, Clare
    Lacey, Katja
    Wijeyaratne, Lihini
    Gammons, Melissa
    Wylie, Emma
    Hulse, Richard P.
    Alsop, Chloe
    Cope, George
    Damodaran, Gopinath
    Betteridge, Kai B.
    Ramnath, Raina
    Satchell, Simon C.
    Foster, Rebecca R.
    Ballmer-Hofer, Kurt
    Donaldson, Lucy F.
    Barratt, Jonathan
    Baelde, Hans J.
    Harper, Steven J.
    Bates, David O.
    Salmon, Andrew H. J.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (08): : 1889 - 1904
  • [10] The Two Stage Model of Preeclampsia: Variations on the Theme
    Roberts, J. M.
    Hubel, C. A.
    [J]. PLACENTA, 2009, 30 : S32 - S37